US FDA Accepts MedinCell, Teva's Application for Bipolar I Disorder Indication for Schizophrenia Drug

MT NewswiresFeb 26 02:54 ET

Teva Pharmaceutical Industries Options Spot-On: On February 25th, 123.86K Contracts Were Traded, With 807.52K Open Interest

Moomoo NewsFeb 25 16:30 ET

Express News | Teva and Medincell Announces FDA Acceptance Of Supplemental New Drug Application for UZEDY(R) Extended-Release Injectable Suspension As A Treatment For Patients With Bipolar I Disorder

BenzingaFeb 25 16:14 ET

Teva Pharmaceutical Industries Limited (TEVA): Among Bourgeon Capital's Top Stock Picks

Yahoo FinanceFeb 25 14:06 ET

Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsFeb 25 06:31 ET · Ratings

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsFeb 25 05:31 ET · Ratings